Rex M. Philpot, Ph.D.
Affiliations: | Psychiatry and Behavioral Neurosciences | University of South Florida, Tampa, FL, United States |
Google:
"Rex Philpot"Mean distance: 17.04 (cluster 6) | S | N | B | C | P |
Parents
Sign in to add mentorCheryl L. Kirstein | grad student | 2004 | University of South Florida | |
(The developing nucleus accumbens septi: Susceptibility to alcohol's effects.) | ||||
Lynn Wecker | research scientist | University of South Florida |
Children
Sign in to add traineeJ Alex Grizzell | research scientist | 2012- | University of South Florida |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Johns BE, Ficken M, Engberg ME, et al. (2021) Increasing dietary choline attenuates spatial memory deficits resulting from exposure to the chemotherapeutic agents cyclophosphamide and doxorubicin. Journal of Psychopharmacology (Oxford, England). 2698811211029752 |
Philpot RM, Ficken M, Johns BE, et al. (2019) Spatial memory deficits in mice induced by chemotherapeutic agents are prevented by acetylcholinesterase inhibitors. Cancer Chemotherapy and Pharmacology |
Wecker L, Marrero-Rosado B, Engberg ME, et al. (2017) 3-Acetylpyridine neurotoxicity in mice. Neurotoxicology. 58: 143-152 |
Philpot RM, Ficken M, Wecker L. (2016) Doxorubicin and cyclophosphamide lead to long-lasting impairment of spatial memory in female, but not male mice. Behavioural Brain Research. 307: 165-175 |
Schroeder RA, Wecker L, Philpot RM. (2016) Obstacles and opportunities for cholinergic drug development in the treatment of cognitive disorders. Current Pharmaceutical Design |
Schroeder RA, Wecker L, Philpot RM. (2016) Obstacles and opportunities for cholinergic drug development in the treatment of cognitive disorders Current Pharmaceutical Design. 22: 1981-1985 |
Lambert CS, Philpot RM, Engberg ME, et al. (2015) Analysis of gait in rats with olivocerebellar lesions and ability of the nicotinic acetylcholine receptor agonist varenicline to attenuate impairments. Behavioural Brain Research. 291: 342-50 |
Philpot RM. (2015) Potential Use of Nicotinic Receptor Agonists for the Treatment of Chemotherapy-Induced Cognitive Deficits. Neurochemical Research |
Lambert CS, Philpot RM, Engberg ME, et al. (2015) Analysis of gait in rats with olivocerebellar lesions and ability of the nicotinic acetylcholine receptor agonist varenicline to attenuate impairments Behavioural Brain Research. 291: 342-350 |
Lambert CS, Philpot RM, Engberg ME, et al. (2014) Gait analysis and the cumulative gait index (CGI): Translational tools to assess impairments exhibited by rats with olivocerebellar ataxia. Behavioural Brain Research. 274: 334-43 |